Stengone Carmine N.
Director, Officer at CTNM
- Sold, on record
- $401k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Sep 8, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CTNMContineum Therapeutics, Inc.Director, Officer
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice CTNMNoticeJun 30, 2026 2026
Filed to sell 10,000 shares ($150k)
Stengone Carmine N., Director, Officer
10b5-1 planFiling
- 2 Form 4 sale CTNMRoutineJun 30, 2026 same day
Sold 10,000 shares at $16.01 ($160k)
Stengone Carmine N., CEO and President
10b5-1 planSold 36.7% of holdings ($436k position)17,217 shares leftFollows a Form 144Filing
- 3 Form 144 notice CTNMNoticeJul 8, 2026 +8 days
Filed to sell 2,500 shares ($36k)
Stengone Carmine N., Director, Officer
10b5-1 plan0.4x usual sizeFiling
- 4 Form 4 sale CTNMRoutineJul 8, 2026 same day
Sold 2,500 shares at $16.00 ($40k)
Stengone Carmine N., CEO and President
10b5-1 planSold 12.7% of holdings ($315k position)17,217 shares left0.4x usual sizeFollows a Form 144Filing
- 5 Form 144 notice CTNMNoticeAug 3, 2026 +26 days
Filed to sell 2,500 shares ($39k)
Stengone Carmine N., Director, Officer
10b5-1 plan0.5x usual sizeFiling
- 6 Form 4 sale CTNMRoutineAug 3, 2026 same day
Sold 2,500 shares at $16.01 ($40k)
Stengone Carmine N., CEO and President
10b5-1 planSold 12.7% of holdings ($316k position)17,217 shares left0.5x usual sizeFollows a Form 144Filing
- 7 Form 144 notice CTNMNoticeSep 8, 2026 +36 days
Filed to sell 2,500 shares ($42k)
Stengone Carmine N., Director, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale CTNMRoutineSep 8, 2026 same day
Sold 2,500 shares at $16.46 ($41k)
Stengone Carmine N., CEO and President
10b5-1 planSold 12.7% of holdings ($325k position)17,217 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 8, 2026 | CTNM | CEO and President | Form 4 sale | 2,500 | $41k | 12.7% | Routine | SEC |
| Sep 8, 2026 | Sep 8, 2026 | CTNM | Director, Officer | Form 144 notice | 2,500 | $42k | Notice | SEC | |
| Aug 3, 2026 | Aug 3, 2026 | CTNM | CEO and President | Form 4 sale | 2,500 | $40k | 12.7% | Routine | SEC |
| Aug 3, 2026 | Aug 3, 2026 | CTNM | Director, Officer | Form 144 notice | 2,500 | $39k | Notice | SEC | |
| Jul 8, 2026 | Jul 8, 2026 | CTNM | CEO and President | Form 4 sale | 2,500 | $40k | 12.7% | Routine | SEC |
| Jul 8, 2026 | Jul 8, 2026 | CTNM | Director, Officer | Form 144 notice | 2,500 | $36k | Notice | SEC | |
| Jun 30, 2026 | Jul 1, 2026 | CTNM | CEO and President | Form 4 sale | 10,000 | $160k | 36.7% | Routine | SEC |
| Jun 30, 2026 | Jun 30, 2026 | CTNM | Director, Officer | Form 144 notice | 10,000 | $150k | Notice | SEC | |
| Feb 25, 2026 | Feb 26, 2026 | CTNM | CEO and President | Form 4 sale | 7,100 | $114k | 32.2% | Routine | SEC |
| Feb 11, 2026 | Feb 13, 2026 | CTNM | CEO and President | Form 4 sale | 400 | $6k | 2.6% | Routine | SEC |
| Feb 11, 2026 | Feb 11, 2026 | CTNM | Director, Officer | Form 144 notice | 7,500 | $118k | Notice | SEC |